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ABSTRACT
Sepsis is one of the significant causes of morbidity and mortality. The burden caused 
by sepsis has continued to increase in recent years in the Korea, highlighting the urgent 
need for the implementation of strategies to improve sepsis treatment outcomes. We 
therefore designed a web-based sepsis registry system (“Korean Registry for Improving 
Sepsis Survival” [KISS]) protocol to be used in hospitals in the Korea for evaluation of the 
epidemiology and clinical characteristics of patients with sepsis, via an analysis of outcome 
predictors. The inclusion criteria of this registry are as follows: adult patients ≥18 years 
admitted to the participating hospitals who are diagnosed with sepsis or septic shock. 
Demographic and clinical information data of the patients will be collected from hospital 
medical records and will be recorded in a case report form, which will be entered into a 
web-based data management system. The analysis of the collected data will be performed 
as follows: (1) epidemiological and clinical characteristics of sepsis and septic shock, (2) 
application of sepsis bundles and antibiotic stewardship, and (3) audit and feedback. In 
conclusion, we aim to build the comprehensive web-based sepsis registry in the Korea 
through a nation-wide network of participating hospitals. Information collected and analyzed 
through the KISS can be used for further improvements in the clinical management of sepsis. 
Furthermore, the KISS will facilitate research leading to the formulation of public health 
policies regarding sepsis bundle and antibiotic stewardship strategies in the Korea.
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INTRODUCTION
Sepsis is one of the significant causes of morbidity and mortality; it stems from a systemic 
inflammatory reaction against infection manifesting in multi-organ failure syndrome. The 
burden of sepsis has been well described with the global annual incidence of sepsis and 
severe sepsis estimated at 31.5 million and 19.4 million, respectively, and 5.3 million deaths 
that suggest a severe sepsis-related mortality rate of around 30% [1]. Even in a high-income 
country such as the United States (US), sepsis continues to be one of the primary healthcare 
issues. A recent US government study revealed that sepsis-related hospitalization was 70% 
more expensive than average hospitalization, accounting for 8.2% of all Medicare costs in 
2013 [2]. The estimated incidence of severe sepsis in the US is 751,000 cases with 215,000 
deaths annually [3]. In the Korea, public awareness of sepsis has been reported to be lower 
than that of other common medical diseases such as acute myocardial infarction and stroke 
[4]. Furthermore, the sepsis-related mortality rate was estimated to be around 30% in the 
Korea [5], and the number of deaths from sepsis has recently increased at the national 
level (2011: 1,835 with a death rate of 3.7/100,000 persons; 2014: 2,503 with a death rate of 
4.9/100,000; 2016: 3,596 with a death rate of 7.0/100,000; 2018: 4,656 with a death rate of 
9.1/100,000) [6]. There is therefore an urgent need for the implementation of strategies to 
improve sepsis treatment outcomes in the Korea.
Early recognition and timely management of sepsis in a systemic manner are the critical 
components recommended by the Surviving Sepsis Guideline [7]. In particular, the early 
administration of antibiotics and fluids as part of the bundle approach, within 3 hours, has 
been emphasized owing to increased mortality risks associated with delayed 3-hour bundle 
sepsis care [8]. As increased compliance with the sepsis care bundle recommended by the 
Surviving Sepsis Guideline showed a reduction in hospital mortality [9, 10], implementation 
of the standardized sepsis care bundle needs to be considered for optimal management of 
sepsis. In addition, our sepsis registry system may serve a valuable role in estimating the 
true incidence of sepsis as well as in monitoring the implementation of and adherence to 
standardized sepsis care bundles. A notable example is the New York State sepsis registry in 
the US [11]. Since 2014, hospitals in the state of New York are required to adopt a sepsis care 
bundle protocol including the early administration of antibiotics and to report on clinical 
data and compliance to the protocol. Increased compliance to the sepsis care bundle protocol 
accompanied by improved sepsis treatment outcomes in a cohort comprising New York State 
hospitals after 2014 was reported in a recent study [12], which suggests significant potential 
benefits associated with the implementation of such a protocol and registry system. There 
is, however, no nation-wide sepsis registry system in the Korea, in spite of the considerable 
incidence and disease burden caused by sepsis. Therefore, we designed a web-based sepsis 
registry system (“Korean Registry for Improving Sepsis Survival” [KISS]) protocol to be 
used in hospitals in the Korea to evaluate the epidemiological and clinical characteristics of 




The oversight committee for the KISS consists of members of the Korean Society of 
Infectious Diseases, who are responsible for the careful execution of the KISS project 
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including the selection of the participating hospitals, the collection and analysis of the data, 
and the education of the research staff. The steering committee consists of members of the 
oversight committee, consultants, and computer development managers. The consultants 
consist of infectious disease physicians and experts in preventive medicine who will provide 
further advice on areas of improvement of the KISS project. The computer development 
managers are in charge of designing and maintaining the web-based registry data 
management system.
2. Study design
The KISS is designed as a prospective multicenter cohort enrolling adult patients with sepsis 
in the Korea. Patients will be screened for eligibility on a monthly basis by trained study 
nurses or physicians at the participating hospitals. Documentation using hospital medical 
records includes the following assessment factors recorded in a case report form (CRF): 
onset of sepsis, initial resuscitation, site of infection and appropriateness of antimicrobial 
treatment, and outcomes. Collected CRF data is submitted to the KISS via the designated 
data collection portal website for further analysis.
3. Study participants
The multicenter hospital-based sepsis cohort will consist of approximately 30 hospitals from 
six major metropolitan cities and four provinces across the Korea. Patients with sepsis or 
septic shock will be identified via screenings by trained study nurses or physicians once a 
month at the participating hospitals across the Korea. The screened patients will be adult 
patients admitted to the hospital or emergency room who are initiated on intravenous 
antibiotics. The inclusion criteria will be as follows: adult patients ≥18 years admitted to 
the participating hospitals who are diagnosed with either (1) sepsis: a clinically suspected 
or microbiologically proven infection with presence of organ dysfunction, defined by a 
Sequential Organ Assessment (SOFA) score increase of more than 2, or (2) septic shock: the 
presence of sepsis with persistent hypotension despite volume resuscitation with the patient 
needing to be on a vasopressor to maintain a mean arterial pressure (MAP) ≥65 mmHg after 
appropriate fluid resuscitation and serum lactate levels >2 mmol/L according to the SEPSIS-3 
criteria [13]. All patients diagnosed with sepsis or septic shock who are eligible according to 
these inclusion criteria will be enrolled into the KISS (Fig. 1).
4. Data collection
Demographic and clinical data of the patients will be collected from hospital medical records 
and will be recorded in a CRF. The following variables will be listed: (1) demographic data 
including age, sex, admitting hospital department, and date of hospital admission; (2) initial 
symptoms and positive physical examination findings; (3) time to initiation of treatment 
against sepsis or septic shock; (4) information regarding the infection including site of 
infection, acquisition setting, category of sepsis, and Pitt bacteremia score; (5) comorbidities 
and presence of indwelling devices; (6) severity of sepsis or septic shock according to the 
Acute Physiology and Chronic Health Evaluation (APACHE) II/III score, the Simplified Acute 
Physiology Score (SAPS) II score, the Sequential Organ Failure Assessment (SOFA) score, and 
the Glasgow Coma Scale; (7) laboratory data and culture study data; (8) data on antibiotics 
including empiric antibiotics treatment and assessment of the appropriateness of antibiotic 
treatment according to the Surviving Sepsis Guideline [7] and culture data; (8) assessment of 
the Surviving Sepsis Campaign bundle (sepsis bundle) application; (9) additional treatments 
including initial fluid therapy, vasopressor, mechanical ventilation, and other therapies such 
as red blood cell transfusion, steroid, and intravenous immunoglobulin; (10) outcomes 
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including duration of hospital stay, mortality (sepsis-related mortality and all-cause mortality), 
and discharge status. The sepsis cohort data CRF is shown in Supplementary Table 1.
5. Sepsis registry system
The KISS system collects data through a web-based data management system, so that the 
research teams from the participating hospitals can report the collected data via a web 
browser. The selection of the registry and maintenance protocol of the KISS system will be 
monitored by the oversight committee. The collected data are securely deposited onto a data 
storage server with an available back-up system. The KISS system enables the analysis of 
collected data and the visualization in tables and figures; the submission of a proposal to the 
oversight committee is however required, and access to the data will only be granted after 
approval by the oversight committee.
6. Ethics
The screening of patients and the data collection processes for the KISS will be initiated after 
each participating hospital has received approval from their institutional review board. The 
oversight committee for the KISS project will follow the recommendations from the institutional 
review board at each participating hospital and shall amend the protocol as needed.
7. Assessments
The annual incidence of sepsis and septic shock at each participating hospital will be 
calculated and, on the basis of these data, the nation-wide annual incidence of sepsis and 
septic shock in the Korea will be estimated.
34https://icjournal.org https://doi.org/10.3947/ic.2020.52.1.31




Patients with infection or
suspicion of infection
Monthly screening of patients
admitted to emergency room,
ward, and intensive care unit
qSOFA ≤1
· Glasgow Coma Scale = 15
· Respiratory rate <22 per minute
· Blood pressure >100 mmHg
· Mean arterial pressure ≥65 mmHg
· Serum lactate ≤2 mmol/L
Evaluate for the followings:
· PaO2/FiO2 ratio
· Glasgow Coma Scale
· Mean arterial pressure
· Vasopressors/infusion dose
· Serum creatinine or urine output
· Bilirubin
· Platelet count
Figure 1. The screening and enrollment process for sepsis cases. 
SOFA score, sequential organ failure assessment score; qSOFA, quick SOFA score.
The epidemiological and clinical characteristics of sepsis and septic shock will be assessed 
using the following data: age, sex, route of hospital admission, duration of fever and 
presenting symptoms, site of infection, classification of sepsis and septic shock, Pitt 
bacteremia score, severity of sepsis (APACHE II score, SAPS II score, SOFA score, Modified 
Early Warning Score), laboratory data, identified pathogens from culture studies, use of 
vasopressors, use of other treatments, and appropriate application of the sepsis bundle. 
Risk factors associated with death from sepsis and septic shock will be assessed in a survival 
analysis. Furthermore, a comparison between the hospitals with high and low sepsis-related 
mortality will be performed to identify hospital- specific factors contributing to higher 
sepsis-related mortality. The role of antibiotic stewardship will be assessed according to 
the following factors: (1) empiric antibiotics: type and class, monotherapy vs. combination 
therapy, dosage and administration, and duration; (2) appropriateness of empiric antibiotics; 
(3) definitive antibiotics: type and class, monotherapy vs. combination therapy, dosage 
and administration, and duration; (4) de-escalation from empiric antibiotics to definitive 
antibiotics. In particular, the effect of the Surviving Sepsis Campaign bundle and antibiotic 
stewardship on 30-day mortality, multidrug-resistant bacterial pathogen infection rates, 
consumption of antibiotics, and durations of hospital stay will be assessed by case-control 
studies between the hospitals with and without implementation of sepsis bundle and 
antibiotic stewardship.
Monthly audits and the monitoring of data collected through the web-based data 
management system will be led by the oversight committee. The completeness and validity of 
the data will be assessed and query notifications will be sent to the participating hospitals if 
needed. Each participating hospital may check and update the collected data on the web site 
to help solve queries. Feedback from the participating hospitals will be sent to the oversight 
committee for further improvement of the KISS system.
8. Statistical analysis
Continuous variables will be compared using independent t-tests or the Mann-Whitney 
test. Categorical variables will be analyzed using Pearson's chi-square test or Fisher's exact 
test. Variables with a P-value <0.1 in the comparison analysis will be included in a multiple 
logistic regression to determine risk factors. Kaplan-Meier curves and Cox proportional 
hazard models will be used for survival analyses. Propensity scores will be constructed to 
ensure balance in baseline characteristics between the hospitals with and without the sepsis 
bundle and antibiotic stewardship in the case-control studies. The variables included in the 
propensity models will be epidemiological and clinical factors. All tests will be two-sided, 
and a P-value <0.05 will be considered statistically significant. Analyses will be performed 
using Stata version 14 (StataCorp LP, College Station, Texas, USA) and SPSS version 24.0 
(IBM SPSS Inc., Chicago, IL, USA).
DISCUSSION
The KISS is the first prospective multicenter cohort registry using a web-based data 
collection system to offer advanced assessment of adult patients with sepsis in the Korea in 
the followings: (1) clinical epidemiology, management including implementation of sepsis 
bundle, and primary outcomes such as death, and (2) secondary outcomes measuring the 
impact of appropriate use of antibiotics and the role of antibiotic stewardship. With this 
comprehensive evaluation of adult patients with sepsis through the collection of clinical data 
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via a web browser, we expect the KISS to offer valuable information on the current clinical 
epidemiological approach to sepsis in real-world settings in the Korea. Although a previous 
study [14] reported mortality and performance rates for individual sepsis bundle elements 
(including lactate measurements, administration of fluids and antibiotics, and central 
pressure measurements) among adult patients with septic shock in the Korea, the data was 
based on a registry from a relatively smaller number of hospitals (n = 10), which limits the 
study's informative value. The KISS registry will be based on a more significant number 
of hospitals (n = 30) across the Korea, and is thus expected to provide a more accurate 
assessment of the clinical epidemiology of sepsis in the Korea.
The KISS will help identify compliance with and variation in the application of sepsis 
bundles at the participating hospitals, as suboptimal compliance and wide variations in the 
application of sepsis bundles among hospitals have been critical issues in the management 
of sepsis [12, 15]. Previous studies [12, 16, 17] have shown that increased compliance with 
sepsis bundles improved outcomes and decreased hospital mortality. Considering that sepsis 
bundle compliance rates increased after the introduction of mandatory reporting via a web-
based sepsis registry system in the state of New York [12], we too expect a more accurate 
identification of compliance rates and a potential increase in sepsis bundle compliance 
after the implementation of the KISS. This information on sepsis bundle compliance will 
help improve sepsis management. While the Surviving Sepsis bundle emphasizes the timely 
administration of broad-spectrum antibiotics to cover possible causative pathogens, this 
approach may adversely increase the use of broad-spectrum antibiotics and thus the risk of 
multidrug-resistant pathogens [18]. Therefore, the appropriateness of antimicrobial treatment 
and antibiotic stewardship in the treatment of sepsis will be assessed. Re-evaluation and 
de-escalation by antibiotic stewardship are the critical aspects of sepsis management and 
need to be integrated, along with the sepsis bundle, to improve the quality and outcomes 
of sepsis management [18]. In Europe (Ireland and United Kingdom), to address this issue, 
goals and effectiveness of antibiotic stewardship efforts have been made integral parts of 
sepsis management [19, 20]. Furthermore, a previous study demonstrated that early antibiotic 
stewardship interventions significantly increased the appropriateness of antibiotic treatment 
in patients with sepsis through de-escalation [21]. However, not much is known regarding the 
impact of sepsis bundles and antibiotic stewardship in sepsis management in the Korea. The 
findings from the planned case-control studies will therefore be used to estimate the impact of 
sepsis bundles and antibiotic stewardship on 30-day mortality, multidrug-resistant bacterial 
pathogen infection rates, consumption of antibiotics, and durations of hospital stay.
Other potential benefits of the KISS are the monthly audits and the data monitoring through 
a web-based data management system. This is similar to the mandatory sepsis reporting 
system in the state of New York [12]. Other countries have also adopted such registry systems. 
For example, all intensive care units in Australia and New Zealand are now contributing to 
an outcome evaluation registry, the ANZIS CORE registry [22]. The ANZIS CORE registry 
collects data and reports back to the participating intensive care units after the audit process. 
In line with these registry systems in other countries, the KISS will contribute to improved 
quality assurance of data management through the audit and feedback process. The KISS will 
also enable the participating hospitals to check the data and update them through distinct 
query and notification features.
The approach described in this study protocol has some limitations. Enrollment of sepsis 
cases will occur on a monthly basis, and data will be collected from the participating 
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hospitals, which might lead to some selection and sampling biases. In addition, confounding 
effects from unmeasured variables might affect the analyses. However, the application of 
multiple logistic regression and propensity scoring will minimize the risks of such biases in 
our analyses. Moreover, recruitment of additional participating hospitals during the study 
period and accumulative analyses are expected to minimize such limitations.
In conclusion, the KISS aims to build the comprehensive web-based sepsis registry in the 
Korea based on a nation-wide network of participating hospitals. The data that will be 
collected and analyzed will provide information of sepsis epidemiology, application of sepsis 
bundles, and the impact of antibiotic stewardship efforts in real-life settings. This valuable 
information can then be used for further improvements in the clinical management of sepsis. 
Furthermore, the KISS will facilitate research that may lead to the formulation of public health 
policies regarding the sepsis bundle and antibiotic stewardship strategies in the Korea.
SUPPLEMENTARY MATERIAL
Supplementary Table 1
The sepsis cohort data CRF is shown in Supplementary Table 1.
Click here to view
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